Sunnie Kim, MD, contextualizes the use of tislelizumab as a frontline treatment option in advanced esophageal squamous cell carcinoma.
Sunnie Kim, MD
Advertisement
Articles by Sunnie Kim, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Clears sNDA for Taletrectinib With Updated DOR Data in ROS1+ NSCLC
2
Updated NCCN Guidelines Feature Additional MRD Recommendations in Multiple Myeloma
3
Dr Bianchi on the Mechanism of Anselamimab in AL Amyloidosis
4
Mosunetuzumab Plus Lenalidomide Improves PFS in R/R Follicular Lymphoma
5